Dimension Therapeutics Receives $65,000,000 Series B Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e457fe9f-80f8-4ab4-833b-3247b45da384 - Date
4/21/2015 - Company Name
Dimension Therapeutics - Mailing Address
840 Memorial Drive 4th Floor Cambridge, MA 02139 USA - Company Description
Dimension Therapeutics is a gene therapy company focused on developing novel treatments for rare diseases. The company was launched in 2013 by Fidelity Biosciences and REGENX Biosciences. Dimension has now raised $30M with funding from Fidelity Biosciences and OrbiMed. - Website
http://www.dimensiontx.com - Transaction Type
Venture Equity - Transaction Amount
$65,000,000 - Transaction Round
Series B - Proceeds Purposes
Dimension plans to use the proceeds from the financing to further advance the company’s adeno-associated virus (AAV) platform and growing pipeline of gene therapy programs. - M&A Terms
- Venture Investor
- Venture Investor
- Venture Investor
- Venture Investor
- Venture Investor
- Venture Investor
- Venture Investor
